Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2025 · 10-Q
Revenue$40.76M$40.76M+0.4% vs Q3 2024 Net Income-$2.95M-$2.95MN/M vs Q3 2024 EPS Diluted-$0.01-$0.01— vs Q3 2024 Gross Profit$16,363,000−2.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,676,000+233.3% Free Cash Flowderived$2,117,000N/M Margins · derivedGross margin40.1%−1.2 pt vs Q3 2024
Operating margin3.9%+0.6 pt vs Q3 2024
Net margin-7.2%−4.8 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end